Mechanical Reperfusion for STEMI: From Randomized Trials to Clinical Practice

As a leading cause of death in developed countries, ST-segment elevation myocardial infarction and its various treatment options are of great concern to those in the cardiology field. This text presents evidence-based chapters that supply clinicians with real-life situations and strategies to treat STEMI patients more effectively and at a quicker pace. A highly illustrated and fully referenced source, this comprehensive text provides both a scientific background and a practical overview of the invasive management of STEMI patients.

Giuseppe De Luca, MD, PhD, is Chief of Interventional Cardiology at the Azienda Ospedaliera-Universitaria "Maggiore della Carit" in Novara, Italy. Having performed over 3,000 coronary angioplasties, Dr. De Luca is a major worldwide expert in the setting of acute myocardial infarction. He is a member of the Scientific Committee of the European Association of Percutaneous Coronary Intervention (EAPCI) and the recipient of several prestigious international scientific awards, including the Thomas J. Linnemeier Spirit of Interventional Cardiology Young Investigator Award. An author of over 100 peer-reviewed journal publications, Dr. De Luca is an Assistant Professor of Cardiology at Eastern Piedmont University. He is Director of the University's Laboratory of Molecular Cardiology, where he is currently conducting several studies on pharmacogenomics, genetic predisposition to atherosclerosis, no-reflow phenomenon, and left ventricular remodeling after STEMI. Alexandra J. Lansky, MD, is Director of Clinical Services of the Center for Interventional Vascular Therapy at the New York-Presbyterian Hospital/Columbia University Medical Center. She is an Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons. An author of over 100 peer-reviewed manuscripts and book chapters, Dr. Lansky is the lead author of the American Heart Association Statement on Interventional Cardiology in Women. She is also a founding member of the Cardiovascular Research Foundation (CRF), where she serves as Joint Chief Scientific Officer for the Clinical Trials Center and Director of the Women's Cardiovascular Health Initiative. She has served as the principle investigator on numerous angiographic and intravascular ultrasound laboratory studies and has furthered her research on women's cardiovascular health.